Gastroesophageal Cancer
📧 Sign up to get email alerts when something new happens for Gastroesophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer. [Phase 1, Phase 2]
The document summarizes a Phase 1/Phase 2 clinical trial evaluating ASKB589 in combination with CAPOX chemotherapy and PD-1 inhibitors for p…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating cabozantinib in combination with pembrolizumab for metastatic gastric cancer and gastroesophageal cancer; results h…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: RegoNivo vs Standard of Care Chemotherapy in AGOC [Phase 3]
Phase 3 clinical trial update comparing RegoNivo (regorafenib + nivolumab) against standard-of-care chemotherapy in gastroesophageal cancer;…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers [Phase 2]
A Phase 2 clinical trial evaluating SBRT/Olaparib followed by Pembrolizumab/Olaparib in gastric and gastroesophageal cancers; currently acti…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours [Phase 3]
This entry describes the Add-Aspirin Phase 3 trial evaluating whether adding aspirin after primary therapy reduces recurrence and improves s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment [Phase 1]
Phase 1 trial update evaluating peri-operative treatment of resectable gastroesophageal cancer with bemarituzumab (BEMA) plus perioperative …
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Feasibility and Effect of Resistance Training and Protein Supplementation in Patients With Advanced Gastroesophageal Cancer [NA]
This clinical trial update assesses the feasibility and potential effects of resistance training and protein supplementation in patients wit…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: First Line gastroeSOphageal metastatiC canceR primAry and disTant (if Oligometastatic) lEsions-directed Radiotherapy, a Multicentric, Phase III, Randomized Controlled Trial [NA]
A multicenter Phase III randomized trial evaluating first-line radiotherapy directed at both primary and distant gastroesophageal cancer les…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Early IntraVenous Administration of Nutritional Support [NA]
The clinical trial evaluating early intravenous administration of nutritional support in patients with stomach cancer and gastroesophageal c…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America
This clinical trial update reports epidemiological characteristics of gastric, gastroesophageal, and pancreatic cancers in Latin America; th…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers [Phase 2]
This Phase 2 trial aims to evaluate whether reducing the dosing frequency of immune checkpoint inhibitors is feasible across advanced cancer…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer [Phase 2]
A Phase 2 study evaluating tusamitamab ravtansine in combination with ramucirumab for pretreated gastric or gastroesophageal cancer has been…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer [Phase 1]
Phase 1 safety and tolerability study of Claudiximab in patients with advanced gastroesophageal cancer has completed, reporting safety findi…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer [Phase 2]
A Phase 2 trial from the University of Southampton is exploring ctDNA-guided adjuvant therapy for gastroesophageal cancer and is currently r…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Cancer-associated Cachexia in Patients With Incurable Gastroesophageal Cancer
This clinical trial is investigating cancer-associated cachexia in patients with incurable gastroesophageal cancer and is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours [Phase 1]
This clinical trial update reports the completion of a first-in-human Phase 1 study evaluating AZD8701 with or without durvalumab in adults …
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer [Phase 2]
A Phase 2 trial comparing nab-paclitaxel plus a PD-1 inhibitor versus nab-paclitaxel alone as second-line therapy in advanced gastric and ga…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer [Phase 2]
A Phase 2 study comparing Modified FOLFOX with or without nivolumab and ipilimumab versus FLOT with nivolumab in previously untreated advanc…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG) [NA]
Clinical trial update for the Anti-Migration System (ANTIMIG) designed to prevent migration of an anti-reflux esophagogastric stent, with re…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluated avelumab with chemoradiation for resectable stage II/III esophageal and gastroesophageal cancer; the study has c…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies [Phase 1]
A Phase 1 trial evaluating immunotherapy combinations in gastrointestinal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers [Phase 2]
Phase 2 trial evaluating APX005M in combination with concurrent chemoradiation for resectable esophageal and gastroesophageal junction cance…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies [Phase 2]
Phase II study evaluating lenvatinib with pembrolizumab in metastatic gastroesophageal and gastric cancer after prior therapies; study compl…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma [Phase 2]
A Phase 2 clinical trial update investigates fruquintinib in combination with SOX as neoadjuvant therapy for locally advanced gastric adenoc…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 [Phase 2]
Phase 2 trial evaluating abemaciclib with pembrolizumab in locally advanced unresectable or metastatic gastroesophageal adenocarcinoma was t…